Total Payments
$7,127
2024 Payments
$1,772
Companies
44
Transactions
374
Medicare Patients
4,494
Medicare Billing
$432,967
Payment Breakdown by Category
Food & Beverage$7,098 (99.6%)
Education$28.79 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,098 | 372 | 99.6% |
| Education | $28.79 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $897.19 | 43 | $0 (2024) |
| PFIZER INC. | $832.44 | 47 | $0 (2024) |
| Novo Nordisk Inc | $549.38 | 29 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $440.57 | 22 | $0 (2024) |
| Lilly USA, LLC | $374.42 | 18 | $0 (2024) |
| GlaxoSmithKline, LLC. | $364.03 | 20 | $0 (2024) |
| Amarin Pharma Inc. | $326.73 | 20 | $0 (2022) |
| Astellas Pharma US Inc | $300.74 | 19 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $298.45 | 17 | $0 (2022) |
| Abbott Laboratories | $231.02 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,772 | 84 | PFIZER INC. ($316.78) |
| 2023 | $1,708 | 92 | PFIZER INC. ($214.42) |
| 2022 | $1,641 | 80 | ABBVIE INC. ($517.67) |
| 2021 | $1,046 | 60 | PFIZER INC. ($149.47) |
| 2020 | $429.18 | 25 | Amarin Pharma Inc. ($98.38) |
| 2019 | $425.52 | 26 | Janssen Pharmaceuticals, Inc ($89.07) |
| 2018 | $90.90 | 6 | Allergan Inc. ($39.34) |
| 2017 | $13.89 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($13.89) |
All Payment Transactions
374 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: PAIN | ||||||
| 12/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: RESPIRATORY | ||||||
| 12/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: Obesity | ||||||
| 12/05/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/02/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: NEUROSCIENCE | ||||||
| 11/25/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Endocrinology | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug), AIRSUPRA, FARXIGA | Food and Beverage | In-kind items and services | $9.96 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $25.94 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Cardiology | ||||||
| 10/31/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: UROLOGY | ||||||
| 10/28/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $25.60 | General |
| Category: PSYCHIATRY | ||||||
| 10/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $26.19 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/17/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/10/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.41 | General |
| Category: Cardiovascular | ||||||
| 10/03/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: Analgesic | ||||||
| 10/03/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Diabetes Care | ||||||
| 09/30/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Insomnia | ||||||
| 09/26/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Hematology | ||||||
| 09/23/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: PAIN | ||||||
| 09/16/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $32.21 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 09/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Oncology | ||||||
| 09/05/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 997 | 1,423 | $222,350 | $103,398 |
| 2022 | 14 | 1,195 | 1,692 | $245,400 | $119,609 |
| 2021 | 14 | 1,197 | 1,724 | $257,870 | $126,184 |
| 2020 | 16 | 1,105 | 1,597 | $228,330 | $83,776 |
Total Patients
4,494
Total Services
6,436
Medicare Billing
$432,967
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 275 | 479 | $83,210 | $42,063 | 50.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 245 | 245 | $61,225 | $32,164 | 52.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 136 | 306 | $44,370 | $17,340 | 39.1% |
| G0181 | Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 2023 | 29 | 66 | $9,900 | $5,549 | 56.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 31 | 35 | $7,000 | $1,486 | 21.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 42 | 42 | $1,450 | $1,310 | 90.3% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 29 | 32 | $6,400 | $1,046 | 16.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 108 | 113 | $5,650 | $928.70 | 16.4% |
| G0102 | Prostate cancer screening; digital rectal examination | Office | 2023 | 38 | 38 | $1,140 | $551.00 | 48.3% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 13 | 14 | $1,020 | $426.47 | 41.8% |
| 99407 | Smoking and tobacco use intensive counseling, more than 10 minutes | Office | 2023 | 11 | 13 | $585.00 | $362.83 | 62.0% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2023 | 40 | 40 | $400.00 | $171.60 | 42.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 306 | 546 | $87,390 | $47,656 | 54.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 282 | 282 | $70,500 | $38,112 | 54.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 160 | 350 | $50,750 | $20,481 | 40.4% |
| G0181 | Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 2022 | 26 | 71 | $10,650 | $6,043 | 56.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 48 | 49 | $1,470 | $1,446 | 98.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 25 | 29 | $5,800 | $1,240 | 21.4% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2022 | 24 | 31 | $6,200 | $1,017 | 16.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 120 | 121 | $6,050 | $1,017 | 16.8% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 47 | 50 | $3,560 | $900.22 | 25.3% |
| G0102 | Prostate cancer screening; digital rectal examination | Office | 2022 | 43 | 43 | $1,290 | $548.84 | 42.5% |
| 99407 | Smoking and tobacco use intensive counseling, more than 10 minutes | Office | 2022 | 13 | 18 | $810.00 | $525.80 | 64.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 14 | 14 | $490.00 | $430.71 | 87.9% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2022 | 44 | 44 | $440.00 | $190.50 | 43.3% |
About Dr. Christopher Superczynski, M.D
Dr. Christopher Superczynski, M.D is a Internal Medicine healthcare provider based in Lincoln, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2005. The National Provider Identifier (NPI) number assigned to this provider is 1184621138.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Superczynski, M.D has received a total of $7,127 in payments from pharmaceutical and medical device companies, with $1,772 received in 2024. These payments were reported across 374 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($7,098).
As a Medicare-enrolled provider, Superczynski has provided services to 4,494 Medicare beneficiaries, totaling 6,436 services with total Medicare billing of $432,967. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Lincoln, RI
- Active Since 07/06/2005
- Last Updated 06/25/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1184621138
Products in Payments
- ELIQUIS (Drug) $675.16
- VRAYLAR (Drug) $524.13
- TRELEGY ELLIPTA (Drug) $328.42
- Vascepa (Drug) $326.73
- UBRELVY (Drug) $322.11
- Ozempic (Drug) $305.97
- XARELTO (Drug) $284.97
- FARXIGA (Drug) $275.36
- FREESTYLE LIBRE 3 (Device) $185.11
- Rybelsus (Drug) $156.89
- GEMTESA (Drug) $156.88
- JARDIANCE (Drug) $154.31
- VOQUEZNA (Drug) $149.78
- XIFAXAN (Drug) $133.60
- PREVNAR 20 (Biological) $125.32
- Yupelri (Drug) $122.78
- MOUNJARO (Drug) $113.94
- Zubsolv (Drug) $110.65
- MYRBETRIQ (Drug) $110.31
- JATENZO (Drug) $109.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lincoln
Brock Cookman, D.o, D.O
Internal Medicine — Payments: $694,509
Internal Medicine $694,509
Dr. Ryan Martin, Md, MD
Internal Medicine — Payments: $414,185
Internal Medicine $414,185
Matthew Johnson, M.d, M.D
Internal Medicine — Payments: $307,471
Internal Medicine $307,471
Dr. Sherri Thomas, Do, DO
Internal Medicine — Payments: $100,336
Internal Medicine $100,336
Frank D'alessandro, Md Inc, MD INC
Internal Medicine — Payments: $86,860
Internal Medicine $86,860
Peter Gallagher, M.d, M.D
Internal Medicine — Payments: $83,162
Internal Medicine $83,162